Physician profile
Jared Taub
NPI 1659786663
$636.73
in general payments reported to CMS, 2019-2025
11 companies · $378 in 2025
The $378 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $60.03 · 2023: $87.29 · 2024: $112 · 2025: $378.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $577.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $576.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $140.97 | 2024-2025 | Wegovy, Rybelsus, Ozempic |
| Glaxosmithkline, LLC. | $104.49 | 2022-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Kvk-Tech, INC. | $93.19 | 2025 | |
| Amgen INC. | $87.98 | 2022-2025 | Repatha, Otezla, Evenity |
| Boston Scientific Corporation | $64.70 | 2023-2024 | Watchman Flx |
| Lilly USA, LLC | $37.29 | 2025 | Mounjaro, Zepbound, Kisunla |
| Exact Sciences Corporation | $31.82 | 2023-2025 | Cologuard Collection Kit |
| Pfizer INC. | $22.07 | 2023 | |
| Merck Sharp & Dohme LLC | $19.49 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $18.66 | 2025 | Breztri |
| Sanofi Pasteur INC. | $16.07 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jared Taub listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.